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Objectives: To estimate the prevalence of undiagnosed chronic obstructive pulmonary
disease (COPD) in a population of general practice patients at risk for developing COPD. A
further aim was to evaluate the presence of respiratory symptoms as a predictor for the
diagnosis of COPD.
Methods: This study was conducted by eight general practitioners (GP) in six semi-rural
general practices. During two consecutive months all patients attending their GP were
included if they met the following criteria: current smokers between 40 and 70 yr of age,
and a smoking history of at least 15 pack-years. A questionnaire regarding smoking history,
respiratory symptoms, exposure to dust or chemical fumes, and history of respiratory
diseases was completed for all patients. Subjects without known COPD were invited for
spirometric testing.
Results: Off the 146 general practice patients included, 17.1% already had an established
COPD diagnosis. Screening by spirometry revealed a 46.6% prevalence of COPD.
Underdiagnosis of COPD was more frequent in the younger age categories (40–49 Yr;
50–59 Yr). Objective wheezing was the only sign that was significantly more frequent in
COPD patients than in non-COPD patients (Po0.001). Patients with previously known COPD
were significantly older, and complained more of chronic cough and fatigue than newly
detected patients.
Conclusion: Almost half of a general practice population of current smokers between 40 and 70
years of age, with a smoking history of at least 15 pack-years, was diagnosed with COPD, and
roughly two thirds of these were newly detected as a result of the case finding programme.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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J. Vandevoorde et al.526Introduction Project, Division of Lung Diseases, National Heart, Lung, andChronic obstructive pulmonary disease (COPD) is a leading
cause of chronic morbidity and mortality. According to the
Global Burden of Disease Study, COPD was the sixth leading
cause of death worldwide in 1990, and it is projected to
become the third commonest cause of death and the fourth
most important disability-producing illness by 2020.1
Furthermore, COPD prevalence is greatly underestimated,
since it is usually not diagnosed until it is clinically apparent
and moderately advanced.2 Cigarette smoking is considered
the most important risk factor for the development of COPD,
and early detection of the disease combined with smoking
intervention programs have been shown to have a beneficial
effect on lung function.3 Spirometry is commonly accepted
as the golden standard for diagnosis and assessment of
COPD,2 and simple and inexpensive handheld office spirom-
eters have now become widely available for use in primary
care.
The overall prevalence of COPD in adults is estimated at
4–10%.4 However, a prevalence of 30–50% has been reported
in high-risk populations, such as long-term smokers, depend-
ing on the characteristics of the population under study and
on the (spirometric) criteria used for diagnosis.5–9 In
previous studies, two methods have been used for the early
detection of COPD: high-risk population screening6–9 and
case finding.5,10 Both methods have their advantages and
disadvantages, making them complementary. The present
study emphasizes the important role of the general
practitioner (GP) in the early detection of COPD. We
propose a case finding method which is easy to implement
in day-to-day primary care, by using the risk factors age and
smoking history to define a population of patients at risk for
developing COPD.
The primary aim of this study was to estimate the
prevalence of undiagnosed COPD in a population of current
smokers aged 40–70 yr, with a smoking history of at least 15
pack-years, visiting a GP’s office during a 2-month study
period. In a second instance, we aimed to evaluate whether
the presence of respiratory symptoms assessed by the GP, in
this cohort of current smokers, could be used as a predictor
for the diagnosis of COPD.
Methods
General design of the study
Eight GPs in six semi-rural general practices participated in
this study, and were asked to register the total number of
patient contacts during a 2-month study period. During this
time all subjects visiting their GP were included on their first
visit if they met the following criteria: active smokers
between 40 and 70 yr of age, with a smoking history of at
least 15 pack-years. A questionnaire concerning smoking
history, respiratory symptoms, exposure to dust or chemi-
cals, and history of respiratory diseases, was completed by
the GP for all these patients. For the development of the
questionnaire (Appendix A), we consulted the ‘‘Recom-
mended Respiratory Disease Questionnaires for use with
Adults and Children in Epidemiological Research’’ (ATS-DLD-
78 Questionnaire of the Epidemiological StandardizationBlood Institute11). Patients with asthma were excluded from
the study. Patients with a known history of COPD (confirmed
by spirometry in the past) did not have further testing, while
all other patients were invited to have spirometric testing.
Pulmonary function testing
Spirometry was performed by the participating GPs, with
their own handheld spirometer (four GPs used a Spirobank S,
Medical International Research, Rome, Italy, and the others
used a One Flow FVC, Medical Electronic Construction,
Brussels, Belgium), according to the ERS guidelines.12 The
GPs received spirometry training, consisting of an internet-
based theoretical course followed by two hands-on sessions
in the lung function laboratory of the Academic Hospital of
the University of Brussels (AZ-VUB). All curves were assessed
by JV and LG; in case of disagreement or uncertainty, results
were discussed with DS or WV. The spirometric parameters
used in this study were: forced expiratory volume in 1 s
(FEV1), forced vital capacity (FVC), FEV1/FVC ratio and
mean forced expiratory flow between 25% and 75% of FVC
(FEF25–75%). Reference values were those of the European
Community for Steel and Coal, approved by the European
Respiratory Society,12 which apply to men and women aged
18–70 yr. Diagnosis of COPD and assessment of severity was
made according to the GOLD guidelines2: FEV1/FVCo70%,
in combination with FEV1X80% of the predicted value
(Stage I), or 50%pFEV1o80% predicted (Stage II), or
30%pFEV1o50% predicted (Stage III), or FEV1o30% pre-
dicted (Stage IV). ‘‘Small airways disease’’ was diagnosed if
FEF25–75% was smaller than 65% of the predicted value.
Statistics
The variables age, pack-years, exposure to dust or chemicals
and respiratory symptoms (chronic cough and sputum
production, dyspnoea at rest or on exertion, objective or
subjective wheezing and fatigue) were examined for their
influence on the odds of having COPD, using both univariate
and multivariate analyses. In the multivariate analysis both
forward and backward stepwise logistic regression analysis
was performed (forward procedure not shown).
Subsequently, the same analysis was performed to
estimate the influence of these explanatory variables in
the comparison of the newly detected and previously known
COPD patients.
Data were analysed with the Statistical Package for the
Social Sciences version 12.0 (SPSS, Chicago, IL).
Results
During the 2-month study period a total of 5755 patient
contacts were registered. Of the 166 subjects meeting the
inclusion criteria, 25 subjects had been diagnosed with
COPD prior to the study. The remaining 141 subjects were
invited to undergo a spirometric examination. Twenty
subjects were excluded from further analysis: 12 because
they refused spirometry or did not show up for their
appointment and eight because they could not perform an
acceptable spirometric test within eight attempts. There
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Table 1 Characteristics of the study population.
Totals Non COPD COPD all COPD known COPD newly detected
N (%) 146 (100) 78 (53.4) 68 (46.6) 25 (17.1) 43 (29.5)
Male/female (%) 62/38 60/40 65/35 64/36 65/35
Age mean, yr (SD) 52.3 (8.7) 50.9 (8.4) 53.9 (8.9) 58.2 (9.3) 51.4 (7.6)
Height mean, cm (SD) 170.1 (8.4) 169.5 (8.0) 170.8 (8.9) 168.5 (8.7) 172.1 (8.8)
Weight mean, kg (SD) 75.2 (14.6) 75.1 (15.2) 75.3 (13.9) 74.7 (13.8) 75.7 (14.2)
Pack years mean, yr (SD) 33.6 (15.8) 31.4 (13.1) 36.2 (18.1) 45.6 (23.3) 30.7 (11.3)
FEV1 %pred mean (SD)
a 89.4 (17.8) 96.1 (14.9) NA NA 77.5 (16.5)
FEV1/FVC mean (SD)
a 72.1 (10.6) 78.1 (6.7) NA NA 61.6 (7.2)
FEF25–75% %pred mean (SD)
a 60.8 (28.2) 74.9 (24.1) NA NA 36.4 (14.8)
Exposure to dust/chemicals, n (%) 54 (37.0) 25 (32.1) 29 (42.6) 13 (52.0) 16 (37.2)
Chronic cough, n (%) 70 (48.0) 30 (38.5) 40 (58.8) 21 (84.0) 19 (44.2)
Chronic sputum production, n (%) 65 (44.5) 30 (38.5) 35 (51.5) 19 (76.0) 16 (37.2)
Dyspnoea (rest), n (%) 6 (4.1) 2 (2.6) 4 (5.9) 2 (8.0) 2 (4.7)
Dyspnoea (exertion), n (%) 77 (52.7) 38 (48.7) 39 (57.4) 19 (76.0) 20 (46.5)
Subjective wheezing, n (%) 55 (37.7) 21 (26.9) 34 (50.0) 16 (64.0) 18 (41.9)
Fatigue, n (%) 69 (47.3) 37 (47.4) 32 (47.1) 17 (68.0) 15 (34.9)
Objective wheezing, n (%) 45 (30.8) 12 (15.4) 33 (48.5) 16 (64.0) 17 (39.5)
Definition of abbreviations: SD ¼ standard deviation, NA ¼ not applicable, FEV1 ¼ forced expiratory volume in 1 s, FVC ¼ forced vital
capacity, FEF25–75% ¼ forced expiratory flow between 25% and 75% of FVC.
aFor subjects who underwent spirometric testing, i.e. subjects without known COPD (n ¼ 121, 62% male).
Table 2 Prevalence of COPD in a group of 146 general practice patients, aged 40–70 yr, with a smoking history of at least 15
pack-years.
Known COPD 25 (17.1%) No previous diagnosis of COPD 121 (82.9%)
Newly detected COPDa 43 (29.5%) Non COPD 78 (53.4%)
Stage Ia Stage IIa Stage IIIa Stage IVa Normal Small airways disease Restrictive pattern
18 (12.3%) 21 (14.4%) 4 (2.7%) 0 45 (30.8%) 26 (17.8%) 7(4.8%)
aDiagnosis and assessment of severity of COPD according to the GOLD criteria.2
Figure 1 Prevalence of known chronic obstructive pulmonary
disease (COPD), newly detected COPD and newly detected small
airways disease (SAD) in a high-risk population (total n ¼ 146):
dependence on age category.
Early detection of COPD in general practice 527was no difference between the 20 excluded subjects and the
study group with respect to age, gender and pack years
(P40:1 for all, data not shown). Characteristics of the study
population are shown in Table 1.
Table 2 shows that 68 (46.6%) of the 146 subjects included
in this study were diagnosed with COPD. The prevalence of
previously known COPD was 17.1%, whereas the prevalence
of previously undetected COPD was 29.5%. Of these newly
detected COPD patients, 91% presented with mild-to-
moderate COPD, according to the GOLD criteria.2 Spiro-
metric signs of ‘‘small airways disease’’ were found in 26
subjects (17.8%). Finally, a restrictive spirometric pattern
was observed in seven subjects (4.8%). Figure 1 illustrates
that subjects with newly detected COPD were more
frequent in the younger age categories (40–49 yr;
50–59 yr). For instance, 30% of the patients aged 40–49 yr
(19 out of 64) had newly detected COPD, compared to only
15% of the patients aged 60–70 yr (five out of 33).
Table 3 shows the results of uni- and multivariate analyses
to identify independent predisposing factors for developing
COPD. When comparing subjects with or without COPD
ARTICLE IN PRESS
Table 3 Odds ratios estimated by logistic regression analysis in a group of 146 general practice patients, aged 40–70 yr, who
are current smokers with a history of at least 15 pack-years.
Variable Univariate analysis (95% CI) Multivariate analysisa (95% CI)
Odds ratio 95% CI P Odds ratio 95% CI P
A. Comparison of subjects with or without COPD
Age (yr) 1.04 1.00–1.08 0.038
Pack-years 1.02 1.00–1.04 0.07 (NS)
Male sex 1.21 0.62–2.37 NS
Objective wheezing 5.19 2.38–11.28 o0.0001 4.72 2.14–10.37 o0.0001
Chronic cough 2.29 1.18–4.44 0.015
Subjective wheezing 2.71 1.36–5.41 0.005
Chronic expectoriations 1.7 0.88–3.28 NS
Dyspnoea (exertion) 1.42 0.74–2.72 NS
Dyspnoea (rest) 2.38 0.42–13.39 NS
Fatigue 0.99 0.51–1.89 NS
Exposure dust/chemicals 1.58 0.80–3.10 NS
B. Comparison of subjects with newly detected or known COPD
Age (yr) 1.10 1.03–1.17 0.003 1.12 1.04–1.21 0.003
Pack-years 1.06 1.02–1.10 0.004
Male sex 0.95 0.34–2.67 NS
Objective wheezing 2.72 0.98–7.54 NS
Chronic cough 6.63 1.94–22.62 0.003 7.64 1.87–31.18 0.005
Subjective wheezing 2.47 0.89–6.83 NS
Chronic expectoriations 5.34 1.77–16.16 0.003
Dyspnoea (exertion) 3.64 1.22–10.90 0.02
Dyspnoea (rest) 1.78 0.24–13.51 NS
Fatigue 3.97 1.39–11.32 0.01 3.99 1.13–14.08 0.032
Exposure dust/chemicals 1.83 0.67–4.96 NS
Definition of abbreviations: 95% CI ¼ 95% confidence interval.
aIn the multivariate analysis, both forward and backward stepwise logistic regression analysis was performed, with identical results.
J. Vandevoorde et al.528(Table 3A), the univariate analysis, with COPD as the
dependent variable, showed that the odds of having COPD
were influenced by the variables age (Odds ratio
[OR] ¼ 1.04), chronic cough (OR ¼ 2.29), subjective wheez-
ing (OR ¼ 2.71) and objective wheezing (OR ¼ 5.19) (Table
3, part A). In the multivariate analysis only objective
wheezing remained an independent predictor for having
COPD (OR ¼ 4.72). When comparing the newly detected
COPD patients with known COPD patients (Table 3B), the
univariate analysis shows that patients were more likely to
have their COPD diagnosed prior to the case finding
programme if they were older, had a history of more pack-
years, and had the following symptoms: fatigue, dyspnoea
on exertion, chronic cough and expectorations. In the
multivariate analysis, only age (OR ¼ 1.12), chronic cough
(OR ¼ 7.64) and fatigue (OR ¼ 3.99) remained indepen-
dently associated with a previous diagnosis of COPD.Discussion
The present study clearly shows an important prevalence of
undiagnosed COPD, when perfoming spirometry in a high-
risk group of general practice patients. Indeed, in our group
of 146 general practice patients with an established COPD
prevalence of 17.1%, screening by spirometry revealed anextra 29.5% of subjects with COPD (Table 2). Thus, with
respect to the total 46.6% COPD prevalence in the high-risk
population under study, almost two thirds of the subjects
with COPD were detected as a result of case finding. Most of
the newly diagnosed COPD patients were aged o60 yr. We
should emphasize that our results are derived from a cohort
of subjects aged 40–70 yr, who were active smokers
with at least 15 pack-years, recruited by a case finding
programme in primary care. Comparison of our results
with previous studies is hampered by differences in
study population selection and definition of airway
obstruction. For instance, Van Schayck et al.10 found that
18% of 169 smokers, aged 35–70 yr, had obstruction, defined
by FEV1 below 80% of predicted. Given that smoking history
was not documented (while it was one of our inclusion
criteria) and that FEV1 was used (instead of FEV1/FVC), a
comparison is almost impossible. A more recent screening
study by Geijer et al.6 was performed on all males aged
40–65 yr (n ¼ 3985), enlisted with a GP in a small city in The
Netherlands. Of the 702 current smokers (with an average of
25 pack-years), without previously documented lung
disease, 30% had an FEV1/FVC ratio o0.7. Given the
similarity of age and smoking history, this result is very
consistent with ours.
In the present study, comparison of subjects with and
without COPD showed that objective wheezing was the only
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other respiratory symptoms associated with COPD did not
contribute to the diagnosis. This is in line with previous
reports indicating that patients’ history and physical
examination are inadequate for diagnosing airflow limita-
tion, except, to some extent, for smoking history and
objective wheezing.13 In fact, a review by Holleman and
Simel13 mentioned that never having smoked cigarettes is
the best finding associated with decreased likelihood of
airflow limitation (‘rules out’), whereas wheezing is
the most potent predictor of having airflow limitation
(‘rules in’).Limitations of the study
Mass screening of the general population for detecting
obstructive lung diseases is not regarded as feasible in the
daily routine of general practice.10 We therefore converted
the 5755 GP patient contacts to a high-risk study population
by considering the first contact of current smokers, aged
40–70 yr, with a smoking history of 15 pack-years or more,
regardless of the reason for their visit to the GP. The choice
of the inclusion criteria to define our study population was
based on the fact that smoking is by far the most important
risk factor for COPD, and smoking cessation is the most
effective intervention to influence the prognosis of the
disease.
While the present study was not intended to determine
overall COPD prevalence in a general practice population,
COPD prevalence in the subgroup of high-risk patients may
have been influenced by two main factors. First, we did not
include ex-smokers with a smoking history of more than 15
pack-years, who could also be considered at risk. However,
it is unpredictable if this would have influenced the
proportion of newly detected versus known COPD patients,
since prior COPD diagnosis may have been the incentive forsmoking cessation. Secondly, we excluded subjects over
70 yr of age, in order to comply with the age restriction
criteria of the used reference values.12 While COPD
prevalence increases with age, our study shows that
the proportion of newly diagnosed COPD declines with age
(Fig. 1). Hence, case finding may have been of limited use
for this age group.
Despite some inevitable limitations imposed by daily
general practice, this study should encourage active detec-
tion of airflow obstruction by means of spirometry in primary
care. Early detection of COPD could have a substantial
impact on public health. Although still controversial,
confronting patients with abnormal spirometry results could
enhance the rate of smoking cessation.14 Early recognition
of the disorder also triggers preventive services, such as
vaccination against influenza and pneumococcus. In addi-
tion, when infected, the diagnosis would be acute exacer-
bation of COPD, and not acute bronchitis, which may have
implications for treatment.Conclusion
Spirometry is an important tool for the early detection of
COPD in general practice. The present study shows an
important prevalence of undiagnosed COPD in a population
of current smokers, aged 40–70 yr, with a smoking history of
at least 15 pack-years. Almost half of these subjects were
diagnosed with COPD, of whom almost two thirds were
detected as a result of the case finding programme.Acknowledgments
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Identification number doctor/patient: ____/____
Date of Birth: ___/___/____ Age: ____
Sex: Male & Female &
PART 1 (to be completed together with the patient)Yes No
Do you smoke: -cigarettes? & &-cigars? & &
-pipe? & &How old were you when you first started regular cigarette smoking? ____
On the average of the entire time you smoked, how many cigarettes did you smoke per day? ____
Profession: _________________ Yes No
In your profession, is there a daily exposure to: -dust? & &-dust or chemical fumes? & &
Hobby: ________________
In the exertion of your hobby, is there a daily exposure to: -dust & &-dust or chemical fumes? & &
Do you have the following symptoms: Yes No
-Do you usually have a cough? & &
-Do you usually bring up phlegm? & &
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walking on stairs)?& &-at rest? & &
-Does your chest ever sound wheezy or whistling? & &
-Are you tired more easily than before? & &
-Did you ever mention these symptoms to your family physician? & &
If you did not, why not? _____________________________________________PART 2 (to be completed by the doctor)
Weight: ____ Height: ____ Lung
auscultation:
_______________
Number of pack-years: ____
the number of pack-years is defined as the number of years of smoking multiplied by the average number of cigarettes
smoked per day, divided by 20 (the number of cigarettes in a standard packet); a standard pouch of tobacco corresponds to
about 50 cigarettes
Medical history Yes No Unknown
-Recurrent respiratory infections in childhood & & &
-Bronchial hyperreactivity & & &
-Asthma & & &
-Allergy & & &
(which one? _________________________)
-COPD & & &
If yes, was it confirmed by spirometry? & & &
If treated, which treatment was prescribed: __________________________
-Other:yyyyyyyyyyReferences
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